ICCC ImmuCell Corp. Total Debt to Capital

ImmuCell Corporation (ICCC) manages a comprehensive livestock health system by integrating First Defense antibodies into calf diets to combat diseases without the use of antibiotics. The patent exclusivity of these products ensures a stable cash flow and sustained demand. The price indicator on the chart, where the value is 0.40, confirms a strong market position that allows the company to index the cost of critical products above inflation rates.

For ImmuCell Corporation, which specializes in veterinary pharmaceuticals for livestock, this indicator serves as a measure of the balance between external financing and internal resources. The ratio of total liabilities to net assets, represented by the total debt-to-equity ratio, determines the business's degree of financial autonomy and its ability to scale production without critical dependence on borrowed funds.